These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. New inotropic drugs for treatment of congestive heart failure. Schwertz DW; Piano MR Cardiovasc Nurs; 1990; 26(2):7-12; discussion 12. PubMed ID: 1969769 [No Abstract] [Full Text] [Related]
14. Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockers. Hilleman DE Pharmacotherapy; 1993; 13(5 Pt 2):88S-93S. PubMed ID: 7901842 [TBL] [Abstract][Full Text] [Related]
15. A novel approach to the development of positive inotropic agents for chronic heart failure. Packer M J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S52-6. PubMed ID: 8907131 [TBL] [Abstract][Full Text] [Related]
16. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1. Colucci WS; Wright RF; Braunwald E N Engl J Med; 1986 Jan; 314(5):290-9. PubMed ID: 2867470 [No Abstract] [Full Text] [Related]
17. [Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?]. Campa PP; Puddu PE; Schiariti M; Monti F; Dawodu AA; Gentile C; Lilla Della Monica PL; Vaccaro M; De Biase L Cardiologia; 1995 Dec; 40(12 Suppl 1):139-50. PubMed ID: 8998706 [No Abstract] [Full Text] [Related]
18. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure. Weber KT; Janicki JS; Jain MC J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397 [TBL] [Abstract][Full Text] [Related]
19. Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failure. Van Tassell BW; Radwanski P; Movsesian M; Munger MA Pharmacotherapy; 2008 Dec; 28(12):1523-30. PubMed ID: 19025433 [TBL] [Abstract][Full Text] [Related]
20. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition. Botha P; Parry G; Dark JH; Macgowan GA J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]